Active

Asterion Therapeutics

Switched

BE0715602553

Rechtspersoon Private limited company 1 establishment

Schaarbeekstraat(MEL) 20D, 9120 Beveren-Kruibeke-Zwijndrecht Vervaardiging van overige farmaceutische producten

Active for

7 year, 9 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -15,448

▲ 14% vs 2021

Profit

Caution

€ -95,406

▼ 269% vs 2021

Debts

High

€ 197,489

▲ 63% vs 2021

Asterion Therapeutics from Beveren-Kruibeke-Zwijndrecht, company number BE0715602553, closed financial year 2025 with a result of € -95,406 after tax. For that financial year Asterion Therapeutics recorded a gross margin of € -15,448 and equity of € -214,025. Compared with financial year 2021, the result moved from € -25,842 to € -95,406. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What happened at Asterion Therapeutics?

What happened at Asterion Therapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 95,406. filed late Source: NBB ↗
  • New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
  • Start of the company according to the CBE. KBO

In short

From € 25,842 loss in 2021 to € 95,406 loss in 2025.

A new publication or filing at Asterion Therapeutics? We notify you, reason included.

Follow Asterion Therapeutics

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

James Troch
Asterion Therapeutics
+6

Behind Asterion Therapeutics is James Troch. James Troch is also behind DIGITAL DARWIN, VENTURE CAMPUS, 247 Energy, Perpetuum Ventures and Perpetuum CropScience.

See the full network in the app

Directors

According to the 2025 annual accounts

James Troch

Director

Also active at: DIGITAL DARWIN, VENTURE CAMPUS, 247 Energy +6 more

Establishments

Establishment units

Physical locations of this company

Registered office

Schaarbeekstraat(MEL) 20D box 1

9120 Beveren-Kruibeke-Zwijndrecht

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0715.602.553
VAT number
BE 0715.602.553
Registered office
Schaarbeekstraat(MEL) 20D bus 1, 9120 Beveren-Kruibeke-Zwijndrecht
Names & denominations
Asterion Therapeutics · Asterion
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
7 December 2018
Peppol
Active · Active since 15 Apr 2026
Activities · NACE

Vervaardiging van overige farmaceutische producten

Vervaardiging van parfums en toiletartikelen

Overige detailhandel in voedingsmiddelen, neg

Vervaardiging van andere voedingsmiddelen, neg

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.

Frequently asked questions

What is the enterprise number of Asterion Therapeutics?
The enterprise number of Asterion Therapeutics is BE0715602553.
What is the address of Asterion Therapeutics?
The registered office of Asterion Therapeutics is located at Schaarbeekstraat(MEL) 20D box 1, 9120 Beveren-Kruibeke-Zwijndrecht.
When was Asterion Therapeutics founded?
Asterion Therapeutics was founded on 7 December 2018.
What is the main activity of Asterion Therapeutics?
The main activity of Asterion Therapeutics is "Vervaardiging van overige farmaceutische producten" (NACE code 21209).
Does Asterion Therapeutics have a website?
No website is currently known for Asterion Therapeutics.
How much profit did Asterion Therapeutics make in 2025?
Asterion Therapeutics recorded a loss after taxes of € 95,406 in financial year 2025.
What is the revenue of Asterion Therapeutics?
As a small company, Asterion Therapeutics is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -15,448.
Where can I find the annual accounts of Asterion Therapeutics?
Asterion Therapeutics files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Asterion Therapeutics?
According to the 2025 annual accounts, the directors of Asterion Therapeutics are: James Troch.
Who owns Asterion Therapeutics?
Behind Asterion Therapeutics is James Troch. James Troch is also behind DIGITAL DARWIN, VENTURE CAMPUS, 247 Energy, Perpetuum Ventures and Perpetuum CropScience.